S |
2019-02-14 09:18:47.0 |
Adverum Biotechnologies |
AAVL |
ADAGE CAPITAL PARTNERS GP |
4.77% |
view |
B |
2017-12-06 17:04:59.0 |
Adverum Biotechnologies |
AAVL |
ADAGE CAPITAL PARTNERS GP |
5.55% |
view |
B |
2017-02-14 10:42:03.0 |
Adverum Biotechnologies |
AAVL |
CADIAN CAPITAL MANAGEMENT |
10.26% |
view |
S |
2016-03-10 10:30:38.0 |
Avalanche Biotechnologies |
AAVL |
BlackRock Inc |
4.9% |
view |
B |
2016-02-12 16:03:00.0 |
Avalanche Biotechnologies |
AAVL |
CADIAN CAPITAL MANAGEMENT |
5.9% |
view |
S |
2016-02-12 08:54:23.0 |
Avalanche Biotechnologies |
AAVL |
WILF ZYGMUNT |
9.1% |
view |
B |
2016-01-28 15:45:31.0 |
Avalanche Biotechnologies |
AAVL |
Man Group plc |
5.34% |
view |
S |
2015-07-14 16:53:26.0 |
Avalanche Biotechnologies |
AAVL |
Flynn James E |
7.19% |
view |
B |
2015-02-13 16:41:38.0 |
Avalanche Biotechnologies |
AAVL |
Chalberg Thomas W |
1.69% |
view |
B |
2015-02-03 16:12:41.0 |
Avalanche Biotechnologies |
AAVL |
FMR LLC |
15.0% |
view |
B |
2014-08-07 16:09:35.0 |
Avalanche Biotechnologies |
AAVL |
Flynn James E |
9.87% |
view |